Insulin Lispro Junior KwikPen (insulin lispro) NDC 0002-7752

Product information

Brand name (proprietary)

Insulin Lispro Junior KwikPenSuffix: Junior KwikPen

Generic name (nonproprietary)

insulin lispro

Active ingredients

Insulin lispro — 100 [iU]/mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Eli Lilly and Company

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 020563

Marketing start

Feb 12, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Insulin (Chemical/Ingredient)

Identifiers

Product ID 0002-7752_6329aa6b-3571-4196-83b0-fc99de56f3abSPL ID 6329aa6b-3571-4196-83b0-fc99de56f3abSPL set ID 97d5e596-aae1-42c9-ae89-c3780959c467RxCUI 242120, 1652639, 1926331UNII GFX7QIS1II

Pharmacologic class

Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002775205 followed by a unit qualifier and the quantity Copy

Package 00002-7752-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under BLA 020563

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.